Actinin: A Potential Drug Target and Biomarker (G63)

Target Name: ACTBP3

NCBI ID: G63

ACTBP3

Other Name(s): Actin, beta pseudogene 3 | ACTB pseudogene 3

Actinin: A Potential Drug Target and Biomarker

Actin, beta pseudogene 3 (ACTBP3) is a gene that encodes a protein known as actinin. Actinin is a protein that is found in various tissues throughout the body, including muscle, heart, and brain. It plays a critical role in the structure and function of these tissues, and is involved in many cellular processes that are important for overall health and disease.

Recent studies have identified ACTBP3 as a potential drug target and biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This has led to a growing interest in the research of ACTBP3 and its potential applications in medicine.

The Protein that is Found in Many Tissues

Actinin is a protein that is found in many tissues throughout the body. It is a member of the actinin-heparin gene family, which includes a variety of actinins that are involved in the structure and function of various tissues. Actinin is involved in many cellular processes that are important for overall health and disease, including:

* Cellular signaling and signaling pathways
* Cellular division and the cytoskeleton
* Cellular transport and vesicle formation
* Cellular signaling and neurotransmission

ACTBP3 is a Form of Actinin

ACTBP3 is a specific gene that encodes a protein known as actinin. It is a member of the actinin-heparin gene family, which includes a variety of actinins that are involved in the structure and function of various tissues. Actinin is a protein that is found in many tissues throughout the body, including muscle, heart, and brain. It plays a critical role in the structure and function of these tissues, and is involved in many cellular processes that are important for overall health and disease.

Recent Studies Have Identified ACTBP3 as a Potential Drug Target

Recent studies have identified ACTBP3 as a potential drug target and biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This has led to a growing interest in the research of ACTBP3 and its potential applications in medicine.

One of the key reasons for the growing interest in ACTBP3 is its involvement in a variety of cellular processes that are important for overall health and disease. As mentioned earlier, ACTBP3 is involved in many cellular signaling pathways, and it is also involved in the regulation of cell division and the cytoskeleton. These processes are important for the development and maintenance of tissues, and are also involved in the development and progression of many diseases.

Another reason for the growing interest in ACTBP3 is its potential as a drug target. Activating actinin has been shown to have a variety of therapeutic effects, including the inhibition of cancer cell growth and the regulation of neurodegenerative diseases. Additionally, ACTBP3 has also been shown to play a role in the development of autoimmune disorders, and may be a potential biomarker for these diseases.

The Potential Applications of ACTBP3

The potential applications of ACTBP3 are vast and varied. As a drug target, ACTBP3 may be used to treat a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Additionally, ACTBP3 may also be used as a biomarker for these diseases, allowing for the early detection and diagnosis of these conditions.

One of the key potential applications of ACTBP3 is its role in the inhibition of cancer cell growth. Studies have shown that Activating actinin has the ability to inhibit the growth

Protein Name: ACTB Pseudogene 3

The "ACTBP3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ACTBP3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets